Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program
Clinical trial NCT02691052 · COMPLETED
Trial details
- NCT number
- NCT02691052
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-01
- Primary completion
- 2019-07-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.